The Lancet
Sherrie Kelly currently serves as a Senior Editor at The Lancet since February 2024 and has been a Global Health Advisor and Global Health Applications Lead at Burnet Institute since October 2015. Significant expertise includes leading modelling teams focusing on HIV, COVID-19, TB, malaria, and maternal-child health, providing research that influences health investment decisions for over 60 countries. Previous roles include Senior Scientist at the Swiss Tropical and Public Health Institute, Affiliate at the HIV Modelling Consortium, and Maternal, Newborn and Child Health Epidemiologist at the Children's Hospital of Eastern Ontario. Sherrie's background also encompasses work with UNAIDS, the Public Health Agency of Canada, and the Government of Manitoba, with a strong focus on epidemiological analysis and public health initiatives. Sherrie holds a Doctor of Philosophy in Infectious Disease Modelling from Monash University, as well as a Master's degree in Molecular Biology and Medical Genetics and a Bachelor's degree in Genetics from the University of Manitoba.
This person is not in any offices
The Lancet
The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (Oct 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.